459 results on '"Saunders, Kevin O."'
Search Results
2. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
3. Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans
4. Mutation-guided vaccine design: A process for developing boosting immunogens for HIV broadly neutralizing antibody induction
5. Engineered immunogens to elicit antibodies against conserved coronavirus epitopes
6. Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
7. Vaccine induction of CD4-mimicking HIV-1 broadly neutralizing antibody precursors in macaques
8. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
9. Vaccine-mediated protection against Merbecovirus and Sarbecovirus challenge in mice
10. Progress with induction of HIV broadly neutralizing antibodies in the Duke Consortia for HIV/AIDS Vaccine Development
11. Guiding HIV-1 vaccine development with preclinical nonhuman primate research
12. Neonatal SHIV infection in rhesus macaques elicited heterologous HIV-1-neutralizing antibodies
13. Contributors
14. Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial
15. Cryo-EM structures of SARS-CoV-2 Omicron BA.2 spike
16. Structural diversity of the SARS-CoV-2 Omicron spike
17. Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials
18. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice
19. Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
20. Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
21. Rapid selection of HIV envelopes that bind to neutralizing antibody B cell lineage members with functional improbable mutations
22. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies
23. Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies
24. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses
25. Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
26. Pandemic Preparedness: Developing Vaccines and Therapeutic Antibodies For COVID-19
27. Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge
28. Neonatal Rhesus Macaques Have Distinct Immune Cell Transcriptional Profiles following HIV Envelope Immunization
29. Microsecond dynamics control the HIV-1 Envelope conformation
30. Cold sensitivity of the SARS-CoV-2 spike ectodomain
31. Targeted selection of HIV-specific antibody mutations by engineering B cell maturation
32. HIV envelope antigen valency on peptide nanofibers modulates antibody magnitude and binding breadth
33. Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
34. Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
35. Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1
36. SARS-CoV-2 Omicron XBB Lineage Spike Structures, Conformations, Antigenicity, and Receptor Recognition
37. Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
38. Broadly neutralizing antibody induction by non-stabilized SARS-CoV-2 Spike mRNA vaccination in nonhuman primates
39. Engineering immunogens that select for specific mutations in HIV broadly neutralizing antibodies
40. Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier
41. Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
42. Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
43. Immune checkpoint modulation enhances HIV-1 antibody induction
44. A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite
45. Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions
46. Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice
47. Identification of CDRH3 loops in the B cell receptor repertoire that can be engaged by candidate immunogens
48. Antibody responses to the HIV-1 envelope high mannose patch
49. Disruption of the HIV-1 Envelope allosteric network blocks CD4-induced rearrangements
50. Difficult-to-neutralize global HIV-1 isolates are neutralized by antibodies targeting open envelope conformations
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.